A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This study is examining how well a dry powder inhaler (DPI) of albuterol medication works to
help adult and adolescent subjects 12 years of age and older with persistent asthma to
improve lung function.
Phase:
Phase 2
Details
Lead Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc. Teva Branded Pharmaceutical Products, R&D Inc.